Inovio Pharmaceuticals INO
NASDAQ INO
$0.84 +0.04 (+5.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Inovio Pharmaceuticals (INO) Goodwill impairment charges (2023)

Updated

Inovio Pharmaceuticals (INO) posted Goodwill impairment charges of $10.51 million for FY2023.

Analysis

Inovio Pharmaceuticals (INO) Goodwill impairment charges (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Inovio Pharmaceuticals 73.09 Mn -110.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 10.51 Mn
API Access

Inovio Pharmaceuticals Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=INO&period=max&api_key=YOUR_API_KEY